<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4996">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 14, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04821986</url>
  </required_header>
  <id_info>
    <org_study_id>Oral SARS-CoV2</org_study_id>
    <nct_id>NCT04821986</nct_id>
  </id_info>
  <brief_title>Oral Manifestation in Patients With SARS-CoV2 Infection.</brief_title>
  <official_title>Oral Manifestation in Patients With SARS-CoV2 Infection.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fayoum University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fayoum University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The oral cavity is particularly susceptible to viral infection with several viruses such as&#xD;
      herpes simplex virus, cytomegalovirus and Zika virus because of its structures, especially&#xD;
      salivary glands and soft tissues Moreover, oral mucosa can be affected by secondary&#xD;
      pathological process of a bacterial or fungal nature due to viral immunosuppression. The oral&#xD;
      cavity could be considered a &quot;biological barometer&quot; of both viral infection and viral&#xD;
      immunosuppression advancement .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The SARS-Cov2 virus was identified in china at the end of 2019 and spread worldwide causing a&#xD;
      global pandemic. Current research showed that SARS-Cov2 virus invades human cells via the&#xD;
      receptor angiotensin-converting enzyme 2 (ACE2) through scRNA-seq data analyses. The study&#xD;
      identified the organs that are at risk and are vulnerable to SARS-CoV-2 infection. Therefore,&#xD;
      cells with ACE2 receptor distribution may become host cells for the virus and cause&#xD;
      inflammatory response in related organs and tissues, such as the tongue mucosa and salivary&#xD;
      glands. These results suggest that oral mucosa could be a target of SARS-CoV-2 infection .&#xD;
&#xD;
      Although many authors reported the presence of oral lesion associated with SARS-CoV2&#xD;
      infection, the prevalence of the oral manifestation and the range of oral manifestation are&#xD;
      still unknown. Further studies are necessary to better understanding of the symptoms of the&#xD;
      SARS-CoV2 virus in order to faster detection. A multidisciplinary team following the patients&#xD;
      could be the key in treatment of the infection and faster recovery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 1, 2021</start_date>
  <completion_date type="Anticipated">June 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>oral manifestation</measure>
    <time_frame>one week</time_frame>
    <description>describe the patient oral manifestation</description>
  </primary_outcome>
  <enrollment type="Anticipated">600</enrollment>
  <condition>SARS-CoV Infection</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with SARS-CoV2 infection confirmed with PCR will be recruited form 3 different&#xD;
        isolation hospitals at Ministry of health and population. Patient selection will be based&#xD;
        on certain inclusion and exclusion criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  A diagnosis of SARS-CoV2 with PCR.&#xD;
&#xD;
          -  Age range from 18-60 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy or contraceptive pills&#xD;
&#xD;
          -  Lactation&#xD;
&#xD;
          -  Any auto-immune disease that could affect the oral mucosa&#xD;
&#xD;
          -  On any neoplastic therapy.&#xD;
&#xD;
          -  Uncontrolled diabetes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alshaimaa A Mohamed, PhD</last_name>
    <phone>+201006047940</phone>
    <email>aas16@fayoum.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Aliaa I Mahrous, PhD</last_name>
    <phone>+201005714585</phone>
    <email>aim11@fayoum.edu.eg</email>
  </overall_contact_backup>
  <results_reference>
    <citation>La Rosa GRM, Libra M, De Pasquale R, Ferlito S, Pedull√† E. Association of Viral Infections With Oral Cavity Lesions: Role of SARS-CoV-2 Infection. Front Med (Lausanne). 2021 Jan 14;7:571214. doi: 10.3389/fmed.2020.571214. eCollection 2020. Review.</citation>
    <PMID>33521007</PMID>
  </results_reference>
  <results_reference>
    <citation>Halboub E, Al-Maweri SA, Alanazi RH, Qaid NM, Abdulrab S. Orofacial manifestations of COVID-19: a brief review of the published literature. Braz Oral Res. 2020 Oct 30;34:e124. doi: 10.1590/1807-3107bor-2020.vol34.0124. eCollection 2020. Review.</citation>
    <PMID>33146320</PMID>
  </results_reference>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 29, 2021</study_first_submitted>
  <study_first_submitted_qc>March 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 30, 2021</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fayoum University</investigator_affiliation>
    <investigator_full_name>Alshaimaa Ahmed shabaan</investigator_full_name>
    <investigator_title>associate professor in oral &amp; maxillofacial Surgery Department</investigator_title>
  </responsible_party>
  <keyword>oral Manifestation</keyword>
  <keyword>SARS-CoV2</keyword>
  <keyword>prevelance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Oral Manifestations</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

